Martha L Arango-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martha L Arango-Rodríguez has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Flavia Bruna
Instituto de Medicina y Biología Experimental de Cuyo (IMBECU), Centro Científico y Tecnológico Mendoza, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Cuyo, Mendoza CP5500, Argentina
2 shared publications - Paulette Conget
Facultad de Medicina Clinica Alemana-Universidad del Desarrollo, Santiago, Chile
2 shared publications - Anita Plaza
Instituto de Medicina, Facultad de Medicina, Universidad Austral de Chile, Valdivia, Chile
1 shared publication Benjamín Erranz
Center for Regenerative Medicine, School of Medicine, Clínica Alemana, Universidad del Desarrollo, Lo Barnechea, 7710162 Santiago, Chile
1 shared publication- Claudia Lucia Sossa Melo
Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia
1 shared publication - David Contador
Centro de Medicina Regenerativa, Facultad de Medicina, Universidad del Desarrollo, Santiago, Chile
1 shared publication
Latest Publications
- Open Access
- 1 January 2016
- Published by Wiley in Stem Cells International
- Vol. 2016 (1) , 1461648
Regenerative Potential of Mesenchymal Stromal Cells: Age‐Related Changes
Preclinical and clinical studies have shown that a therapeutic effect results from mesenchymal stromal cells (MSCs) transplant. No systematic information is currently available regarding whether donor age modifies MSC regenerative potential on cutaneous wound healing. Here, we evaluate whether donor age influences this potential. Two different doses of bone marrow MSCs (BM‐MSCs) from young, adult, or old mouse donors or two doses of their acellular derivatives mesenchymal stromal cells (acd‐MSCs) were intradermally injected around wounds in the midline of C57BL/6 mice. Every two days, wound healing was macroscopically assessed (wound closure) and microscopically assessed (reepithelialization, dermal‐epidermal junction, skin appendage regeneration, granulation tissue, leukocyte infiltration, and density dermal collagen fibers) after 12 days from MSC transplant. Significant differences in the wound closure kinetic, quality, and healing of skin regenerated were observed in lesions which received BM‐MSCs from different ages or their acd‐MSCs compared to lesions which received vehicle. Nevertheless, our data shows that adult’s BM‐MSCs or their acd‐MSCs were the most efficient for recovery of most parameters analyzed. Our data suggest that MSC efficacy was negatively affected by donor age, where the treatment with adult’s BM‐MSCs or their acd‐MSCs in cutaneous wound promotes a better tissue repair/regeneration. This is due to their paracrine factors secretion.
- 1 January 2016
- Published by Wiley in Stem Cells International
- Vol. 2016 (1) , 1461648
Open AccessRegenerative Potential of Mesenchymal Stromal Cells: Age‐Related Changes
Preclinical and clinical studies have shown that a therapeutic effect results from mesenchymal stromal cells (MSCs) transplant. No systematic information is currently available regarding whether donor age modifies MSC regenerative potential on cutaneous wound healing. Here, we evaluate whether donor age influences this potential. Two different doses of bone marrow MSCs (BM‐MSCs) from young, adult, or old mouse donors or two doses of their acellular derivatives mesenchymal stromal cells (acd‐MSCs) were intradermally injected around wounds in the midline of C57BL/6 mice. Every two days, wound healing was macroscopically assessed (wound closure) and microscopically assessed (reepithelialization, dermal‐epidermal junction, skin appendage regeneration, granulation tissue, leukocyte infiltration, and density dermal collagen fibers) after 12 days from MSC transplant. Significant differences in the wound closure kinetic, quality, and healing of skin regenerated were observed in lesions which received BM‐MSCs from different ages or their acd‐MSCs compared to lesions which received vehicle. Nevertheless, our data shows that adult’s BM‐MSCs or their acd‐MSCs were the most efficient for recovery of most parameters analyzed. Our data suggest that MSC efficacy was negatively affected by donor age, where the treatment with adult’s BM‐MSCs or their acd‐MSCs in cutaneous wound promotes a better tissue repair/regeneration. This is due to their paracrine factors secretion.
- 1 March 2015
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 119 (3) , e216-e217
Local Administration of Allogeneic Mesenchymal Stem Cells (MSCs) at Dysplasia Stage Retards the Progression of Oral Squamous Cell Carcinoma (OSCC)
- 1 March 2015
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 119 (3) , e216-e217
Local Administration of Allogeneic Mesenchymal Stem Cells (MSCs) at Dysplasia Stage Retards the Progression of Oral Squamous Cell Carcinoma (OSCC)